Clinical Trial Update: Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of vorinostat in combination with vinorelbine for patients with advanced cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)
• Vorinostat (vorinostat)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Malignant Solid Tumour | Phase 1 | Status: TERMINATED